Navigation Links
SyncMedical Receives ANVISA Regulatory Approval to Offer Spine and Internal Medicine Products in Brazil

STOUGHTON, Mass., Jan. 5, 2011 /PRNewswire/ -- SyncMedical LLC today announced that the Brazilian ANVISA (Agencia Nacional de Vigilancia Sanitaria – Brazilian National Health Surveillance Agency) has approved their Ethos Spine Pedicle Screw System for sale in Brazil. SyncMedical's Ethos Spine product line was developed to fulfill the need for quality and cost effective treatment solutions to surgeons in the ever-growing, ever-changing field of spine surgery. The Ethos Spine product line provides U.S. manufactured minimally invasive solutions to fit the needs of the global medical community. Ethos product offerings include the Ethos C-Spacer, the Ethos PEEK VBR System and the above mentioned Ethos Pedicle Screw System.

Earlier this month SyncMedical also received ANVISA approval for the Spirus Medical Endo-Ease Discovery System.  SyncMedical is the exclusive Latin American distributor for Spirus Medical, Inc. a core product line of SyncMedical's Internal Medicine Division.

Spirus Medical, Inc. is a leader in bringing novel innovations to the GI market. The company pioneered the concept of "spiral endoscopy" with the introduction of the Endo-Ease Discovery ® SB for deep enteroscopy and the Vista® Retrograde for colonoscopy and ileoscopy. These rotate-to-advance technologies utilize a spiral element on an over-tube to advance and anchor medical devices in natural orifices of the body or a surgically created opening. The company is presently developing a flexible endoscope with an integral drive to power a single use spiral component.

SyncMedical LLC

SyncMedical LLC is an affiliated company of STD Med, Inc. SyncMedical develops, produces and markets medical devices exclusively for regions outside of the United States by leveraging its strategic partnerships with industry leaders and medical professionals. SyncMedical is focused on developing access to the next generation of medical innovations. Our product development partners and our global team of representatives work together at every stage to provide solutions for the international medical community.

STD Med, Inc.

STD Med, Inc. is a rapidly growing and emerging leader in the development and manufacture of medical devices and precision machined components. Established in 1953, STD Med, Inc. is a privately held company. Over the past several years STD Med, Inc. has incubated and invested in several new technologies including Angiolink Corporation (acquired by Medtronic), Arthrosurface Inc., Spirus Medical, Inc. and Cardiosolutions, Inc. and it is our intention to continue to pursue disruptive innovation in the medical device marketplace.

SOURCE SyncMedical LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
5. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
6. CryoCor Receives FDA Approval for Right Atrial Flutter
7. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
8. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
9. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
10. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
11. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
Post Your Comments:
(Date:11/26/2015)... November 27, 2015 ... --> Medical alert ... system (PERS) market is expected ... years with APAC being the ... see a high CAGR between ...
(Date:11/26/2015)... UTRECHT, the Netherlands , November 26, 2015 /PRNewswire/ ...   A new combination approach blends immunotherapy ... --> A new combination approach blends immunotherapy with ... A new combination approach blends immunotherapy with ... the Netherlands has found that immunotherapy ...
(Date:11/26/2015)... Research and Markets ( ) has announced ... Outlook to 2019 - Rise in Cardiac Disorders and Growing ... to their offering. Boston ... scientific and others. --> The market ... Boston scientific and others. ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced ... offering customers 10% off of their purchase of lice treatment product. In addition, customers ... According to a company spokesperson. “Finding lice is a sure way to ruin the ...
(Date:11/27/2015)... ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that ... ). More than 3.7 billion people under the age of 50 – or 67% ... WHO's first global estimates of HSV-1 infection . , "The data shocks us highly!" ...
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television series, ... interesting show that delves into an array of issues that are presently affecting Americans. ... from open dialogue, this show is changing the subjects consumers focus on, one episode ...
(Date:11/27/2015)... Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... Commission on Accreditation of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic ... list of CAAHEP accredited colleges, as only one of twelve colleges and universities in ...
(Date:11/27/2015)... ... 27, 2015 , ... Avid collector, Andrew Hawley from Vintage Rock Posters, announces ... This is one of Joplin's most famous and beautiful concert posters. The concert was ... in Ann Arbor. The According to Hawley, "It is hard to believe that Joplin's ...
Breaking Medicine News(10 mins):